Pathophysiology of Post-COVID syndromes: a new perspective
Most COVID-19 patients recovered with low mortality; however, some patients experienced
long-term symptoms described as “long-COVID” or “Post-COVID syndrome”(PCS). Patients …
long-term symptoms described as “long-COVID” or “Post-COVID syndrome”(PCS). Patients …
Cerebral dysfunctions caused by sepsis during ageing
T Manabe, MT Heneka - Nature Reviews Immunology, 2022 - nature.com
Systemic inflammation elicited by sepsis can induce an acute cerebral dysfunction known as
sepsis-associated encephalopathy (SAE). Recent evidence suggests that SAE is common …
sepsis-associated encephalopathy (SAE). Recent evidence suggests that SAE is common …
Interactions of SARS-CoV-2 with the blood–brain barrier
Emerging data indicate that neurological complications occur as a consequence of severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. The blood–brain barrier …
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. The blood–brain barrier …
CSF biomarkers in COVID-19 associated encephalopathy and encephalitis predict long-term outcome
M Guasp, G Muñoz-Sánchez… - Frontiers in …, 2022 - frontiersin.org
Patients with coronavirus disease 2019 (COVID-19) frequently develop acute
encephalopathy and encephalitis, but whether these complications are the result from viral …
encephalopathy and encephalitis, but whether these complications are the result from viral …
The multifaceted role of neurofilament light chain protein in non-primary neurological diseases
The advancing validation and exploitation of CSF and blood neurofilament light chain
protein as a biomarker of neuroaxonal damage has deeply changed the current diagnostic …
protein as a biomarker of neuroaxonal damage has deeply changed the current diagnostic …
Inflammation at the crossroads of COVID-19, cognitive deficits and depression
Acute neurological alterations have been associated with SARS-CoV-2 infection.
Additionally, it is becoming clear that coronavirus disease 2019 (COVID-19) survivors may …
Additionally, it is becoming clear that coronavirus disease 2019 (COVID-19) survivors may …
Viral antigen and inflammatory biomarkers in cerebrospinal fluid in patients with COVID-19 infection and neurologic symptoms compared with control participants …
A Edén, A Grahn, D Bremell, A Aghvanyan… - JAMA network …, 2022 - jamanetwork.com
Importance Neurologic symptoms are common in COVID-19, but the central nervous system
(CNS) pathogenesis is unclear, and viral RNA is rarely detected in cerebrospinal fluid (CSF) …
(CNS) pathogenesis is unclear, and viral RNA is rarely detected in cerebrospinal fluid (CSF) …
SARS‐COV‐2 infection and Parkinson's disease: possible links and perspectives
Parkinson's disease (PD) is a neurodegenerative disorder characterized by the progressive
loss of dopaminergic neurons in the substantia nigra. The hallmarks are the presence of …
loss of dopaminergic neurons in the substantia nigra. The hallmarks are the presence of …
Widespread white matter oedema in subacute COVID-19 patients with neurological symptoms
While neuropathological examinations in patients who died from COVID-19 revealed
inflammatory changes in cerebral white matter, cerebral MRI frequently fails to detect …
inflammatory changes in cerebral white matter, cerebral MRI frequently fails to detect …
[HTML][HTML] Therapeutic approaches to the neurologic manifestations of COVID-19
EL Graham, IJ Koralnik, EM Liotta - Neurotherapeutics, 2022 - Elsevier
As of May 2022, there have been more than 527 million infections with severe acute
respiratory disease coronavirus type 2 (SARS-CoV-2) and over 6.2 million deaths from …
respiratory disease coronavirus type 2 (SARS-CoV-2) and over 6.2 million deaths from …